Lenvatinib

From IDWiki
Revision as of 19:27, 17 September 2024 by Aidan (talk | contribs) (Created page with "* Multiple receptor tyrosine kinase inhibitor (TKI) that inhibits VEGF receptors * Indicated for thyroid cancer, renal cell carcinoma, and hepatocellular carcinoma * Hypertension is a common side effect * Other adverse effects include heart failure, QT prolongation, renal failure, proteinuria, diarrhea, poor wound healing and fistula formation Category:Oncology Category:Medications")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
  • Multiple receptor tyrosine kinase inhibitor (TKI) that inhibits VEGF receptors
  • Indicated for thyroid cancer, renal cell carcinoma, and hepatocellular carcinoma
  • Hypertension is a common side effect
  • Other adverse effects include heart failure, QT prolongation, renal failure, proteinuria, diarrhea, poor wound healing and fistula formation
Retrieved from "https://idwiki.org/index.php?title=Lenvatinib&oldid=10635"
Powered by MediaWiki
Powered by Semantic MediaWiki